1. Home
  2. BOSC vs INTS Comparison

BOSC vs INTS Comparison

Compare BOSC & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B.O.S. Better Online Solutions

BOSC

B.O.S. Better Online Solutions

HOLD

Current Price

$4.87

Market Cap

28.6M

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.40

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOSC
INTS
Founded
1990
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
24.0M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
BOSC
INTS
Price
$4.87
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.25
AVG Volume (30 Days)
59.5K
1.2M
Earning Date
11-25-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
N/A
EPS
0.51
N/A
Revenue
$48,333,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.71
N/A
Revenue Growth
19.49
N/A
52 Week Low
$3.30
$0.19
52 Week High
$6.72
$2.80

Technical Indicators

Market Signals
Indicator
BOSC
INTS
Relative Strength Index (RSI) 53.26 45.43
Support Level $4.80 $0.39
Resistance Level $5.16 $0.44
Average True Range (ATR) 0.25 0.02
MACD 0.01 -0.00
Stochastic Oscillator 55.23 17.79

Price Performance

Historical Comparison
BOSC
INTS

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: